Aurinia Pharmaceuticals Posts $31.7 Million Q3 Net Income, Revenue of $83.7 Million

Aurinia Pharmaceuticals Inc. (AUPH) on Friday reported third-quarter net income of $31.7 million, or 23 cents per share, with revenue of $83.7 million for the period. The Edmonton, Alberta-based biotechnology company guided full-year revenue to a range of $325 million to $330 million. Aurinia shares have risen almost 8% since the start of the year and are up 41% over the past 12 months.